These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 183135)

  • 1. In vitro inhibition of cyclic AMP phosphodiesterase by cortisol.
    Schmidtke J; Wienker T; Flügel M; Engel W
    Nature; 1976 Aug; 262(5569):593-4. PubMed ID: 183135
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic AMP phosphodiesterase inhibition by coumarins and furanocoumarins.
    Sardari S; Nishibe S; Horita K; Nikaido T; Daneshtalab M
    Pharmazie; 1999 Jul; 54(7):554-6. PubMed ID: 10445247
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of adenosine-3',5'-cyclic monophosphate phosphodiesterase by potential antiallergic compounds.
    Tateson JE; Trist DG
    Life Sci; 1976 Jan; 18(2):153-61. PubMed ID: 56695
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphodiesterase inhibition by succinic and related acid biphenylalkyl monoesters.
    Rogers ME; Boots SG; Boots MR
    J Pharm Sci; 1979 Jul; 68(7):903-5. PubMed ID: 222890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibition of rat heart and brain cyclic adenosine-3',5'-monophosphate phosphodiesterase in vitro under the influence of neurohormone C].
    Galoian AA; Gurvits BIa; Pogosian MA
    Biull Eksp Biol Med; 1977 Jun; 83(6):691-3. PubMed ID: 195650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of heart and brain cyclic adenosine 3',5'-monophosphate phosphodiesterase by new non-steroidic compounds structurally related to natural cardenolides.
    Nemoz G; Prigent AF; Pacheco H
    Biochem Pharmacol; 1978; 27(24):2769-74. PubMed ID: 216370
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of cyclic nucleotide phosphodiesterase activity by an endogenous factor.
    Ho RJ; Russell TR; Asakawa T; Hucks MW
    J Cyclic Nucleotide Res; 1975; 1(2):81-8. PubMed ID: 177458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of chlorphenesin and divalent metal ions with phosphodiesterase.
    Edelson J; McMullen JP
    Arch Int Pharmacodyn Ther; 1976 Sep; 223(1):24-33. PubMed ID: 187130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of adenosine 3',5'-cyclic monophosphate phosphodiesterase by flavonoids. II.
    Nikaido T; Ohmoto T; Sankawa U; Tomimori T; Miyaichi Y; Imoto Y
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):654-61. PubMed ID: 2842074
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of 3',5'-cyclic nucleotide 3'-phosphohydrolase by a novel 1',2'-cyclic nucleotide.
    Nair V; Wiechert RJ; Young DA
    J Cyclic Nucleotide Res; 1982; 8(3):181-90. PubMed ID: 6187785
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of divalent metals on the specificity of inhibitors of the cyclic nucleotide phosphodiesterases from bovine heart.
    Donnelly TE; Barron B
    Biochim Biophys Acta; 1981 Jan; 657(1):168-78. PubMed ID: 6260197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of a high molecular weight cyclic 3',5'-nucleotide phosphodiesterase isolated from rat liver.
    Rhoads AR; Olowofoyeku AK; West WL; Morris HP
    Biochem Pharmacol; 1976 Jan; 25(1):97-9. PubMed ID: 175802
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of beef cortex membrane-bound 3', 5'-AMP phosphodiesterase by halogenated purines.
    Macdonald IA
    Pharmacol Res Commun; 1977 Jan; 9(1):49-58. PubMed ID: 194263
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
    Sakamoto N; Terai M; Takenaka T; Maeno H
    Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines].
    Polyansky NB; Smirnov LD; Shvedova AA; Kagan VE; Tkachuk VA
    Vopr Med Khim; 1983; 29(1):123-7. PubMed ID: 6301154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of CuCl2 on the hydrolysis of cyclic GMP and cyclic AMP by the activator-dependent cyclic nucleotide phosphodiesterase from bovine heart.
    Donnelly TE
    Biochim Biophys Acta; 1978 Oct; 543(3):273-82. PubMed ID: 213129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible participation of glucocorticoid in elevation of 3',5'-cyclic AMP levels through inhibition of cyclic AMP phosphodiesterase.
    Tanigawa Y; Kitamura A; Kawamura M; Shimoyama M; Fujii K; Kohri Y; Ueda I
    Physiol Chem Phys; 1978; 10(5):443-8. PubMed ID: 220644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of a protein from rat testis which inhibits cyclic AMP-dependent protein kinase and phosdiesterase.
    Beale EG; Dedman JR; Means AR
    J Biol Chem; 1977 Sep; 252(18):6322-7. PubMed ID: 197087
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effect of some flavonoids and falvonoid mixtures on cyclic AMP phosphodiesterase activity of rat heart.
    Petkov E; Nikolov N; Uzunov P
    Planta Med; 1981 Oct; 43(2):183-6. PubMed ID: 6273955
    [No Abstract]   [Full Text] [Related]  

  • 20. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
    Koch HP; Bachner J; Löffler E
    Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.